30827-51-1 Usage
Chemical structure
The compound has a pyridinium core with a benzyl group and an amine group with an acetyl group attached.
Functional groups
It contains a chlorine atom and a fluorosulfonyl group attached to the benzyl group.
Target enzyme
The compound is a potential inhibitor of acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine.
Potential applications
It may have potential applications in the treatment of conditions such as Alzheimer's disease.
Binding affinity
The chemical structure suggests that it may have high binding affinity and potency for its target enzyme.
Development
It is a promising lead compound for further development as a therapeutic agent.
Molecular weight
456.7 g/mol
Appearance
The compound is likely to be a solid, based on its molecular weight and structure.
Solubility
The compound's solubility is not explicitly mentioned, but it may be soluble in organic solvents such as dimethyl sulfoxide (DMSO) or methanol, given its lipophilic nature.
Stability
The compound's stability is not explicitly mentioned, but it may be sensitive to hydrolysis or decomposition under certain conditions, such as high temperatures or in the presence of nucleophiles.
Synthesis
The synthesis of the compound is not described in the material provided, but it likely involves multiple steps, including the formation of the benzyl group, the attachment of the fluorosulfonyl group, and the formation of the acetylated amine group.
Purity
The purity of the compound is not mentioned, but it is important to consider when evaluating its potential as a therapeutic agent, as impurities may affect its efficacy and safety.
Toxicity
The toxicity of the compound is not mentioned, but it is an important factor to consider when evaluating its potential as a therapeutic agent, as it may have off-target effects or cause adverse reactions.
Pharmacokinetics
The pharmacokinetic properties of the compound, such as absorption, distribution, metabolism, and excretion, are not mentioned, but they are important factors to consider when evaluating its potential as a therapeutic agent.
Check Digit Verification of cas no
The CAS Registry Mumber 30827-51-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,8,2 and 7 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 30827-51:
(7*3)+(6*0)+(5*8)+(4*2)+(3*7)+(2*5)+(1*1)=101
101 % 10 = 1
So 30827-51-1 is a valid CAS Registry Number.
